Therapeutic relevance of pharmacogenetic factors in cardiovascular medicine

被引：23

作者：

Nakagawa, K ^{[1
]}

Ishizaki, T ^{[1
]}

机构：

[1] Kumamoto Univ, Grad Sch Clin Pharm, Dept Pharmacol & Therapeut, Kumamoto 8620973, Japan

来源：

PHARMACOLOGY & THERAPEUTICS | 2000年 / 86卷 / 01期

关键词：

pharmacogenetics; polymorphism; cytochromes P-450 (CYPs); cardiovascular drugs; cardiovascular diseases; pharmacodynamics;

D O I：

10.1016/S0163-7258(99)00066-2

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The variability in the individual response to drugs may be due either to interindividual variations in the pharmacokinetics of the drugs or to the heterogeneity of the mechanism(s) underlying the diseases, or both. In both cases, genetic heterogeneity is involved in the metabolism of cardiovascular drugs and pathogenesis of inherited cardiovascular disorders. Molecular genetic technologies can now provide sensitive and efficient genetic testing, not only to identify polymorphic drug metabolism genes, but also to identify disease-associated genes for diagnosis and risk stratification of many hereditary cardiovascular diseases. In this review, we discuss the polymorphic metabolism of cardiovascular drugs and the molecular genetics of cardiovascular diseases in relation to the genes determining the responsiveness to a given drug. (C) 2000 Elsevier Science Inc. All rights reserved.

引用

页码：1 / 28

页数：28

共 360 条

[141] Haplotypes of angiotensinogen in essential hypertension [J].

Jeunemaitre, X ;

Inoue, I ;

Williams, C ;

Charru, A ;

Tichet, J ;

Powers, M ;

Sharma, AM ;

GimenezRoqueplo, AP ;

Hata, A ;

Corvol, P ;

Lalouel, JM .

AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 60 (06) :1448-1460

[142] MOLECULAR-BASIS OF HUMAN HYPERTENSION - ROLE OF ANGIOTENSINOGEN [J].

JEUNEMAITRE, X ;

SOUBRIER, F ;

KOTELEVTSEV, YV ;

LIFTON, RP ;

WILLIAMS, CS ;

CHARRU, A ;

HUNT, SC ;

HOPKINS, PN ;

WILLIAMS, RR ;

LALOUEL, JM ;

CORVOL, P .

CELL, 1992, 71 (01) :169-180

[143] INHERITED AMPLIFICATION OF AN ACTIVE GENE IN THE CYTOCHROME-P450 CYP2D LOCUS AS A CAUSE OF ULTRARAPID METABOLISM OF DEBRISOQUINE [J].

JOHANSSON, I ;

LUNDQVIST, E ;

BERTILSSON, L ;

DAHL, ML ;

SJOQVIST, F ;

INGELMANSUNDBERG, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11825-11829

[144] Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10 [J].

Julier, C ;

Delepine, M ;

Keavney, B ;

Terwilliger, J ;

Davis, S ;

Weeks, DE ;

Bui, T ;

Jeunemaitre, X ;

Velho, G ;

Froguel, P ;

Ratcliffe, P ;

Corvol, P ;

Soubrier, F ;

Lathrop, GM .

HUMAN MOLECULAR GENETICS, 1997, 6 (12) :2077-2086

[145]

Kalow W, 1997, PHARMACOL REV, V49, P369

[146] Human P450 metabolism of warfarin [J].

Kaminsky, LS ;

Zhang, ZY .

PHARMACOLOGY & THERAPEUTICS, 1997, 73 (01) :67-74

[147]

KAPLAN NM, 1994, TXB HYPERTENSION, P811

[148] FAMILIAL GLUCOCORTICOID RESISTANCE CAUSED BY A SPLICE SITE DELETION IN THE HUMAN GLUCOCORTICOID RECEPTOR GENE [J].

KARL, M ;

LAMBERTS, SWJ ;

DETERAWADLEIGH, SD ;

ENCIO, IJ ;

STRATAKIS, CA ;

HURLEY, DM ;

ACCILI, D ;

CHROUSOS, GP .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (03) :683-689

[149] DISORDERS OF STEROID 17-ALPHA-HYDROXYLASE DEFICIENCY [J].

KATER, CE ;

BIGLIERI, EG .

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1994, 23 (02) :341-357

[150] Lack of association between the α-adducin locus and essential hypertension in the Japanese population [J].

Kato, N ;

Sugiyama, T ;

Nabika, T ;

Morita, H ;

Kurihara, H ;

Yazaki, Y ;

Yamori, Y .

HYPERTENSION, 1998, 31 (03) :730-733

← 10 11 12 13 14 15 16 17 18 19 →